Induction Healthcare Group PLC
INHC.L
London Stock Exchange9.75
GBp
-0.13
- -
Induction Healthcare Group PLC
INHC.L
(London Stock Exchange)
Recent
price
9.75
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Induction Healthcare Group PLC Induction Healthcare Group PLC (INHC.L) provides software solutions that transform care delivery and the patient journey in hospitals, enabling healthcare providers and administrators to deliver remote and face-to-face care with greater flexibility, control, and accessibility for patients. The company offers a suite of SaaS products including Zesty, a patient engagement platform with smart appointment management, paperless letters, digital questionnaires, patient information, and integrated video consultations deployed in 20 NHS Trusts across England; Attend Anywhere, a secure video consultation platform used by approximately 95 Trusts in England, six Health Boards, and one Trust in Wales; and additional tools such as patient portals with two-way integration into leading electronic patient record systems, digital forms, waitlist validation, and patient-initiated follow-up management, all designed for seamless integration with electronic medical record platforms to enhance operational efficiency, patient outcomes, and workflow in challenging healthcare environments. Incorporated in 2019 and headquartered in London, United Kingdom, Induction Healthcare Group PLC operates primarily in the United Kingdom with deployments across nearly every hospital in the British Isles, and serves markets including Europe, the United States, Australia, Ireland, Canada, the Middle East, Singapore, India, and New Zealand, targeting public and private hospitals, health systems, governments, and electronic medical record providers. In April 2025, the company announced a recommended cash acquisition by VitalHub Corp. valuing it at approximately £9.7 million, with the transaction completed on June 19, 2025, integrating Induction as part of VitalHub UK, a subsidiary of VitalHub Corp., to leverage synergies in patient engagement and telehealth across complementary markets and expand product offerings globally; this followed recent developments such as a new contract in the Republic of Ireland and an address change to Edwin Coe LLP at 2 Stone Buildings, Lincoln's Inn, London, in July 2025, alongside a name change from PLC to Limited in the corporate registry. For the fiscal year ended March 31, 2024, the company reported revenues of £14.4 million with a 78.4% gross margin, driven by £4.9 million from Zesty and £8.8 million from Attend Anywhere, positioning it as a key growth engine in digital health infrastructure amid rising demand for remote consultations and patient self-management tools.